CNF2024 (BIIB021)

BIIB021 · Biogen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNF2024 (BIIB021), covering 2009-06-05 to 2009-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL [Phase 1]